Mayo researchers, collaborators affirm useful blood biomarker for group of brain disorders in new study - EurekAlert

A test of protein in the blood gets further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a group of brain disorders with few treatment options. These disorders are characterized by changes in behavior, cognition, language …

JACKSONVILLE, Fla. — A test of protein in the blood gets further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a group of brain disorders with few treatment option… [+4234 chars]

full article...